Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
for IgA Nephropathy
37 locations incl. Birmingham
Sponsor: Calliditas Therapeutics AB
Sex: All·Age: 18+
Code: NCT06712407·Phase 4·Recruiting